Amgen Drops Drug Delivery Partnership, Targets Crohn’s Disease with TScan Pact

The biotech company shuffled deals around Tuesday, dropping a four-year collaboration with Israel’s Entera Bio and picking a new partner in Massachusetts-based TScan Therapeutics.